Table 2.
Suggested electroporation conditions for several leukemia cell lines
| Cell line | Electroporation condition | % viability via cell counting | % viability via MTS assay |
|---|---|---|---|
| MOLT4 | 250 V, 2.0 ms | 86 | 79 |
| JURKAT | 200 V, 2.5 ms | 81 | 62 |
| GDM-1 | 250 V, 4.0 ms | 95 | 63 |
| Kasumi-2 | 200 V, 4.0 ms | 81 | 53 |
| LOUCY | 250 V, 4.0 ms | 83 | 87 |
| MOLT-16 | 250 V, 2.0 ms | N/A | 75 |
| UT-7 | 350 V, 1.0 ms | N/A | 77 |
| SUPT-13 | 200 V, 4.5 ms | N/A | 81 |
| HBPALL | 250 V, 3.5 ms | N/A | 85 |
| SKW-3 | 200 V, 4.5 ms | N/A | 75 |
| PEER | 200 V, 4.5 ms | N/A | 90 |
| CCRF | 250 V, 3.0 ms | N/A | 89 |
| RPMI-8402 | 250 V, 3.0 ms | N/A | 60 |
| PF-382 | 250 V, 3.0 ms | N/A | 70 |
| AML-1 | 250 V, 3.0 ms | N/A | 53 |
| ML-1 | 250 V, 3.0 ms | N/A | 72 |
| HL-60 | 250 V, 3.0 ms | N/A | 63 |
| TF-1 | 250 V, 3.0 ms | N/A | 62 |
| HT-93 | 300 V,3.0 ms | N/A | 80 |
| Primary myeloid cells | 275 V,5.0 ms | ||
| Primary lymphoid cells | 250 V, 4.0 ms |
Note: The electroporation conditions might slightly vary from above suggested conditions because of variation in cell clones. Therefore it is recommended to optimize own conditions around the above-given parameters